Clinical Case Reports (Dec 2024)

Intranasal Dexmedetomidine Administration Precipitates Respiratory Failure in Child With Croup and Asthma

  • William E. Novotny,
  • Pam Fox,
  • Dynita Haislip

DOI
https://doi.org/10.1002/ccr3.9602
Journal volume & issue
Vol. 12, no. 12
pp. n/a – n/a

Abstract

Read online

ABSTRACT Intranasal dexmedetomidine administration in clinically recommended doses has a small but important risk of causing catastrophic respiratory failure in the setting of preexisting severe respiratory workloads.

Keywords